Update shared on 14 Nov 2025
Analysts have maintained their fair value estimate for Fineotex Chemical at ₹29.4 per share. They cite stable forecasts for the company's growth and profitability outlook.
What's in the News
- A board meeting is scheduled for November 14, 2025, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025 (Board Meeting).
- A 10-for-1 stock split has been announced and will be effective October 31, 2025 (Stock Splits & Significant Stock Dividends).
- An amendment to the Capital Clause of the Memorandum of Association was approved at the Extraordinary General Meeting on October 25, 2025 (Changes in Company Bylaws/Rules).
- The Extraordinary General Meeting on October 25, 2025, included proposals to increase authorised share capital and to issue bonus equity shares in the ratio of 4:1, pending requisite approvals (Special/Extraordinary Shareholders Meeting).
- The board meeting on September 27, 2025, considered the declaration of interim dividend, share capital alteration, sub-division or split of shares, and approval for a bonus issue (Board Meeting).
Valuation Changes
- Fair Value Estimate remains unchanged at ₹29.4 per share.
- Discount Rate has fallen slightly from 13.52% to 13.33%.
- Revenue Growth projection is stable at 18.59%.
- Net Profit Margin forecast remains steady at 23.93%.
- Future P/E ratio has decreased marginally from 23.23x to 23.11x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.